Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Munich - Delayed Quote • EUR Innoviva Inc (HVE.MU) Follow Compare 16.40 0.00 (0.00%) At close: April 4 at 8:02:13 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for HVE.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: HVE.MU View More All News Press Releases SEC Filings Victoria’s Secret, Bitdeer, and More Stocks See Activist Action WEX, Lamb Weston, and More Stocks See Action From Activist Investors Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference Innoviva Full Year 2024 Earnings: EPS: US$0.37 (vs US$2.75 in FY 2023) Innoviva: Q4 Earnings Snapshot Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years Innoviva enters distribution, license agreement with Basilea for Zevtera Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)